Drug
Sarilumab
Sarilumab: highest development phase Phase 3, developed by Sanofi. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sanofi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Sarilumab NCT01709578 | Phase 3 | Rheumatoid Arthritis |
| Sarilumab NCT02373202 | Phase 3 | Rheumatoid Arthritis |
Latest
No recent events.
Follow Sarilumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.